FDA-Approved SPRAVATO® Treatment
A BREAKTHROUGH TREATMENT FOR ADULTS WITH MAJOR DEPRESSIVE DISORDER (MDD) OR TREATMENT-RESISTANT DEPRESSION (TRD)
Suicidal Thoughts & Behaviors
SPRAVATO® is also prescribed for depressive symptoms in adults with major depressive disorder (MDD) who have suicidal thoughts or behaviors.
For Treatment-Resistant Depression
About 33% of patients with depression fail to achieve remission despite treatment with multiple oral antidepressants. SPRAVATO® is the only FDA-approved treatment option that works for TRD.
Unique Mechanism of Action
SPRAVATO® works differently by affecting the glutamate pathway—the most abundant excitatory neurotransmitter in your brain—blocking certain receptors to help improve depression symptoms.